Boston (ChatterShmatter)- The diabetes drug Avandia finds itself under major scrutiny due to some safety concerns around it’s usage.
A recent study into the drug manufactured by GlaxoSmithKline shows a higher rate of heart failure in those who use the drug.
Dr. Wolfgang Winklemayer of Brigham Women’s Hospital in Boston led the study which was later published in the Archives of Internal Medicine.
The study focused on drugs in the same class as Avandia and put them to a head to head comparison.
The diabetes drug Actos from Takeda Pharmaceuticals is the recommended drug for older patients since the results of the study show lower risks of heart failure and death.
An interesting side note is that neither drug showed any difference in the risk of heart attack or stroke.